Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Muraro

Showing results (21-30 of 234) with videos related to

Pageof 24
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 14, 2020
Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: Current StatusAlice Mariottini, Eleonora De Matteis, Paolo A Muraro
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 2, 2008
New visions for anaphylaxis: an iPAC summary and future trendsA Muraro, G Roberts, F Estelle R Simons
Brain : a Journal of Neurology|February 3, 2026
A tight match: comparing the effectiveness of immune reconstitution therapies for multiple sclerosisPaolo A Muraro, Eleonora De Matteis, Antonio Scalfari
Current Opinion in Neurology|July 15, 2003
Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challengesPaolo A Muraro, Riccardo Cassiani Ingoni, Roland Martin
Cytotherapy|March 15, 2005
Using stem cells in multiple sclerosis therapiesP A Muraro, R Cassiani-Ingoni, R Martin
Frontiers in Immunology|September 29, 2022
Antibody-mediated cell depletion therapies in multiple sclerosisAlice Mariottini, Paolo A Muraro, Jan D Lünemann
European Journal of Neurology|July 20, 2010
Positron emission tomography imaging in multiple sclerosis-current status and future applicationsL Kiferle, M Politis, P A Muraro, et al.
Journal of Neuroimmunology|May 25, 1999
Plaques, T cells and beyond: report on an international meeting on the immunological basis of multiple sclerosis held at the University of Chieti, ItalyP A Muraro, R Martin, H Lassmann, et al.
Neurology|March 20, 2019
Author response: Rare side effects of alemtuzumab remind us of the need for postmarketing surveillancePaolo A Muraro, Neil J Scolding, Robert J Fox
Neurology|April 1, 2018
Rare side effects of alemtuzumab remind us of the need for postmarketing surveillancePaolo A Muraro, Neil J Scolding, Robert J Fox
Pageof 24

Showing results (21-30 of 234) with videos related to

Sort By:
Pageof 24
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 14, 2020
Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: Current StatusAlice Mariottini, Eleonora De Matteis, Paolo A Muraro
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 2, 2008
New visions for anaphylaxis: an iPAC summary and future trendsA Muraro, G Roberts, F Estelle R Simons
Brain : a Journal of Neurology|February 3, 2026
A tight match: comparing the effectiveness of immune reconstitution therapies for multiple sclerosisPaolo A Muraro, Eleonora De Matteis, Antonio Scalfari
Current Opinion in Neurology|July 15, 2003
Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challengesPaolo A Muraro, Riccardo Cassiani Ingoni, Roland Martin
Cytotherapy|March 15, 2005
Using stem cells in multiple sclerosis therapiesP A Muraro, R Cassiani-Ingoni, R Martin
Frontiers in Immunology|September 29, 2022
Antibody-mediated cell depletion therapies in multiple sclerosisAlice Mariottini, Paolo A Muraro, Jan D Lünemann
European Journal of Neurology|July 20, 2010
Positron emission tomography imaging in multiple sclerosis-current status and future applicationsL Kiferle, M Politis, P A Muraro, et al.
Journal of Neuroimmunology|May 25, 1999
Plaques, T cells and beyond: report on an international meeting on the immunological basis of multiple sclerosis held at the University of Chieti, ItalyP A Muraro, R Martin, H Lassmann, et al.
Neurology|March 20, 2019
Author response: Rare side effects of alemtuzumab remind us of the need for postmarketing surveillancePaolo A Muraro, Neil J Scolding, Robert J Fox
Neurology|April 1, 2018
Rare side effects of alemtuzumab remind us of the need for postmarketing surveillancePaolo A Muraro, Neil J Scolding, Robert J Fox
Pageof 24